Release Date: 12/06/14 14:23 Summary: Extension of Offer Period Price Sensitive: Yes Download Document 157.07KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%